Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Doris Peterkin0
Marc A. Cohen0
Date of Patent
August 13, 2024
0Patent Application Number
167586820
Date Filed
October 23, 2018
0Patent Citations
Patent Primary Examiner
Patent abstract
The disclosure features, inter alia, combination therapies comprising pembrolizumab and one or more immunogenic XBP1-, CD138-, and CS1-derived peptides. The therapies herein can be used, e.g., for inducing an immune response in a subject having a cancer, and treating a cancer such as breast cancer, e.g., triple negative breast cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
